Pieris Pharmaceuticals Inc (PIRS): Narxning sotuvga nisbati

Pieris Pharmaceuticals Inc (PIRS) kompaniyasining korporativ logotipi

Pieris Pharmaceuticals (PIRS) saraton va o'pka kasalliklariga qarshi kurashish uchun Anticalin protein texnologiyalarini global miqyosda joriy etishni maqsad qilgan, shu bilan birga P/S koeffitsiyenti tarixi GURU.Markets platformasida tahlil uchun mavjud bo'lib, u yerda 821.20 darajasi muhim mezon vazifasini o'taydi. Yirik alyanslarning tugatilishidan keyingi joriy restrukturizatsiya qat'iy tartibga soluvchi nazoratni talab qiladi va rivojlanish raqobatbardosh ish haqi orqali yetakchi biologlarni jalb qilishga bog'liq.

Pieris (PIRS): P/S multiplikatori 04.07.2022dan 31.12.2025gacha

Pieris (PIRS) kompaniyasining tahliliy kesimlari

- aksiya narxi va baholash bo'yicha konsensus prognoz:
Narxlar dinamikasi grafigi pieris.com|PIRS - Maqsadli narxlar grafigi
- birja kapitallashuvi ma'lumotlari:
Bozor bahosi Pieris|PIRS - Korxona qiymati
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
Aksiya hisobiga sof aktivlar Pieris Pharmaceuticals|PIRS - Balans kapitallashuvi|Bozor qiymatining balans qiymatiga koeffitsiyenti pieris.com|PIRS - Kompaniyaning jami aktivlari
- qarz majburiyatlari va likvidlik statistikasi:
Barcha qarzlarning o‘z mablag‘lariga nisbati Pieris Pharmaceuticals|PIRS - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga koeffitsiyenti Pieris Pharma|PIRS - Kompaniya qarzlari|Sof aktivlarga qarzlar Pieris|PIRS - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli kredit va qarzlari Pieris Pharmaceuticals|Kritik likvidlik koeffitsiyenti pieris.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
PIRS - Sof foyda|Kutilayotgan sof daromad Pieris Pharmaceuticals|PIRS - P/E multiplikatori|Forvard P/E multiplikatori Pieris Pharmaceuticals Inc|PIRS - Narxning foydaga va o‘sish sur’atiga nisbati|Biznes qiymatining amortizatsiya chegirilishidan oldingi operatsion foydaga nisbati Pieris|PIRS - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|So'nggi 12 oy davomida bir aksiya uchun sof foyda Pieris Pharmaceuticals|PIRS - Bir aksiya uchun sof foyda (EPS TTM)|Choraklik EPS foyda o'sishi pieris.com|PIRS - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun kutilayotgan foyda o'sishi Pieris Pharmaceuticals
- emitentning tushumi va sotuvlari tafsilotlari:
PIRS - Daromad va sotish hajmi|Kompaniyaning kutilayotgan sotish hajmi pieris.com|PIRS - Kapitalizatsiyaning daromadga nisbati|Forvard P/S multiplikatori Pieris
Kompaniyaning fundamental tahlili:PIRS, pieris.com
Pieris Pharmaceuticals tayyor mahsulotlari

Bozor qiymatini hosil qilingan daromadga nisbatan baholash xavfsizlik zaxirasi yuqori bo'lgan aktivlarni tanlash uchun juda muhimdir. Ushbu sotuvlarga nisbatan narx koeffitsiyenti Pieris Pharmaceuticals (PIRS) kompaniyasining bozor kapitalizatsiyasini anti-kalin proteinlaridan tushgan litsenziya daromadlari hamda AstraZeneca va Servier kompaniyalaridan olingan royalti to'lovlari bilan bog'laydi, bu esa investorlarga ushbu metrikaning tarixiy tendentsiyasini tahlil qilish orqali innovatsion dori vositalari salohiyati uchun to'langan premiumni aniqlash imkonini beradi.

Pieris Pharmaceuticals kimlar bilan raqobatlashadi

HLN (haleon.com) - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Kenvue KVUE|VRNA (Verona Pharma PLC) - Narxning sotuvga nisbati|Jyong Biotech Corp - P/S multiplikatori|Narx/daromad koeffitsiyenti Ligand Corp LGND|AMRX: P/S multiplikatori|Sotuvga nisbatan narx perrigo.com (PRGO)|Narxning daromadga nisbati Alvotech SA|LQDA: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori GLPG|Narx/daromad koeffitsiyenti ANI Pharmaceuticals Corp|Narxning daromadga nisbati MannKind Corporation MNKD|Narx/daromad koeffitsiyenti amphastar.com (AMPH)|PCRX: Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati SPRY (ARS Pharmaceuticals Inc)|Theravance (TBPH) - Narxning daromadga nisbati|Narxning sotuvga nisbati AQST (Aquestive Corp)|SCPH (scPharmaceuticals, Inc.) - P/S multiplikatori|TECX: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori TNXP|P/S multiplikatori sxtchina.com (SXTC)|Narxning daromadga nisbati Eupraxia Pharmaceuticals Inc. EPRX|Bozor kapitallashuvining daromadga nisbati BHST|EXOZ - Narxning daromadga nisbati|Oramed Pharmaceuticals (ORMP) - Kapitalizatsiyaning daromadga nisbati|ENTX: P/S multiplikatori|MindWalk Holdings, Inc. (HYFT) - P/S multiplikatori|ABVC (ABVC BioPharma Inc) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati Cumberland Corp (CPIX)|P/S multiplikatori QNTM|FGEN - Sotuvga nisbatan narx|Telomir Pharmaceuticals, Inc. - Kapitalizatsiyaning daromadga nisbati|P/S multiplikatori Rani Therapeutics Holdings RANI|SNYR: Kapitalizatsiyaning daromadga nisbati|Rallybio Corporation - Kapitalizatsiyaning sotish hajmiga nisbati|LEXX: P/S multiplikatori|PULM - Narx/daromad koeffitsiyenti|PTHL (Pheton Holdings Limited) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati Aptorum (APM)|P/S multiplikatori LYRA|P/S multiplikatori Impact BioMedical, Inc. (IBO)|Narxning daromadga nisbati TNF Pharmaceuticals, Inc. TNFA|cbdMD Inc. - Narxning daromadga nisbati|PRFX - Narxning daromadga nisbati|Narx/daromad koeffitsiyenti Altamira Therapeutics CYTO|Lipella (LIPO) - Narxning daromadga nisbati|Narxning sotuvga nisbati OPTN (OptiNose Corp)|PROC (Procaps Group S.A.) - P/S multiplikatori|petrospharma.com (PTPI) - Narx/daromad koeffitsiyenti|Narxning daromadga nisbati Qilian International Holding (QLI)|SLRN (Acelyrin Inc.) - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati TFF Pharma TFFP